(2026). 26 | Validation of a new multi-target antioxidant treatment for the therapy of Duchenne muscular dystrophy. European Journal of Translational Myology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"26 | Validation of a New Multi-target Antioxidant Treatment for the Therapy of Duchenne Muscular Dystrophy."
European Journal of Translational Myology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"26 | Validation of a New Multi-target Antioxidant Treatment for the Therapy of Duchenne Muscular Dystrophy."
European Journal of Translational Myology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.